AskBio’s Late-Onset Pompe Disease Gene Therapy AB-1009 Cleared for Phase 1/2 Trial | NeurologyLive - Clinical Neurology News and Neurology Expert Insights
6:00
AskBio’s Late-Onset Pompe Disease Gene Therapy AB-1009 Cleared for Phase 1/2 Trial | NeurologyLive - Clinical Neurology News and Neurology Expert Insights
4 months ago
neurologylive.com
See more
Static thumbnail place holder